MCID: SZR006
MIFTS: 59

Seizure Disorder

Categories: Genetic diseases, Neuronal diseases, Rare diseases

Aliases & Classifications for Seizure Disorder

MalaCards integrated aliases for Seizure Disorder:

Name: Seizure Disorder 53 6 3
Seizures 29 6 42
Epilepsy 71
Seizure 29

Classifications:



External Ids:

UMLS 71 C0014544

Summaries for Seizure Disorder

NINDS : 53 The epilepsies are a spectrum of brain disorders ranging from severe, life-threatening and disabling, to ones that are much more benign. In epilepsy, the normal pattern of neuronal activity becomes disturbed, causing strange sensations, emotions, and behavior or sometimes convulsions, muscle spasms, and loss of consciousness. The epilepsies have many possible causes and there are several types of seizures. Anything that disturbs the normal pattern of neuron activity—from illness to brain damage to abnormal brain development—can lead to seizures. Epilepsy may develop because of an abnormality in brain wiring, an imbalance of nerve signaling chemicals called neurotransmitters, changes in important features of brain cells called channels, or some combination of these and other factors. Having a single seizure as the result of a high fever (called febrile seizure) or head injury does not necessarily mean that a person has epilepsy. Only when a person has had two or more seizures is he or she considered to have epilepsy. A measurement of electrical activity in the brain and brain scans such as magnetic resonance imaging or computed tomography are common diagnostic tests for epilepsy.

MalaCards based summary : Seizure Disorder, also known as seizures, is related to seizures, benign familial infantile, 3 and benign neonatal seizures, and has symptoms including seizures, tremor and back pain. An important gene associated with Seizure Disorder is DIAPH1 (Diaphanous Related Formin 1), and among its related pathways/superpathways are Neuroscience and L1CAM interactions. The drugs Ethosuximide and Nitrazepam have been mentioned in the context of this disorder. Affiliated tissues include brain, temporal lobe and cortex, and related phenotypes are mortality/aging and nervous system

MedlinePlus : 42 Seizures are symptoms of a brain problem. They happen because of sudden, abnormal electrical activity in the brain. When people think of seizures, they often think of convulsions in which a person's body shakes rapidly and uncontrollably. Not all seizures cause convulsions. There are many types of seizures and some have mild symptoms. Seizures fall into two main groups. Focal seizures, also called partial seizures, happen in just one part of the brain. Generalized seizures are a result of abnormal activity on both sides of the brain. Most seizures last from 30 seconds to 2 minutes and do not cause lasting harm. However, it is a medical emergency if seizures last longer than 5 minutes or if a person has many seizures and does not wake up between them. Seizures can have many causes, including medicines, high fevers, head injuries and certain diseases. People who have recurring seizures due to a brain disorder have epilepsy. NIH: National Institute of Neurological Disorders and Stroke

CDC : 3 Epilepsy is a broad term used for a brain disorder that causes seizures. There are many different types of epilepsy. There are also many different kinds of seizures.

Wikipedia : 74 Epilepsy is a group of neurological disorders characterized by recurrent epileptic seizures. Epileptic... more...

Related Diseases for Seizure Disorder

Diseases in the Seizure Disorder family:

Seizures, Benign Familial Infantile, 1 Seizures, Benign Familial Infantile, 2
Seizures, Benign Familial Infantile, 3 Seizures, Benign Familial Infantile, 4
Seizures, Benign Familial Infantile, 5 Scn1a-Related Seizure Disorders

Diseases related to Seizure Disorder via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 2925)
# Related Disease Score Top Affiliating Genes
1 seizures, benign familial infantile, 3 34.3 SCN2A KCNQ2
2 benign neonatal seizures 33.7 SCN2A SCN1A PNPO KCNQ2 CDKL5
3 malignant migrating partial seizures of infancy 33.6 TBC1D24 SCN2A SCN1A
4 benign familial neonatal epilepsy 33.2 SCN2A SCN1A KCNQ2 CDKL5
5 benign familial infantile epilepsy 33.0 SCN2A SCN1A KCNQ2 CDKL5
6 epilepsy, nocturnal frontal lobe, 1 32.5 SCN1A KCNQ2
7 genetic epilepsy with febrile seizures plus 32.4 SCN2A SCN1A
8 episodic ataxia 31.9 SCN2A SCN1A KCNQ2
9 early onset absence epilepsy 31.8 SCN2A SCN1A KCNQ2
10 christianson syndrome 31.7 MECP2 CDKL5
11 lubs x-linked mental retardation syndrome 31.6 MECP2 CDKL5
12 epileptic encephalopathy, early infantile, 9 31.5 SCN2A SCN1A KCNQ2 CDKL5
13 valproate embryopathy 31.4 NLGN1 MECP2
14 early myoclonic encephalopathy 31.4 TBC1D24 SCN2A SCN1A KCNQ2 CDKL5
15 chromosome 1p36 deletion syndrome 31.0 TBC1D24 NAALADL2 MECP2
16 partial motor epilepsy 31.0 TBC1D24 SCN2A SCN1A KCNQ2
17 epileptic encephalopathy, early infantile, 1 30.7 TBC1D24 SCN1A KCNQ2
18 low-grade astrocytoma 30.4 SCN2A SCN1A
19 visual epilepsy 30.3 SCN2A SCN1A PNPO MECP2 KCNQ2 CDKL5
20 electroclinical syndrome 30.3 TBC1D24 SCN2A SCN1A MECP2 KCNQ2 CDKL5
21 encephalopathy 30.2 SCN1A PNPO MECP2 CDKL5
22 epileptic encephalopathy, early infantile, 6 30.2 TBC1D24 SCN2A SCN1A PNPO MECP2 KCNQ2
23 hypertelorism 30.1 WHCR SCN1A MECP2
24 landau-kleffner syndrome 29.8 SCN2A SCN1A KCNQ2 CDKL5
25 lennox-gastaut syndrome 29.7 SCN2A SCN1A MECP2 KCNQ2 CDKL5
26 generalized epilepsy with febrile seizures plus 29.7 SCN2A SCN1A KCNQ2 CDKL5
27 epilepsy with generalized tonic-clonic seizures 29.7 SCN2A SCN1A
28 autosomal dominant nocturnal frontal lobe epilepsy 29.5 SCN2A SCN1A PNPO KCNQ2
29 epilepsy, myoclonic juvenile 29.4 SCN2A SCN1A PNPO KCNQ2 CILK1 CDKL5
30 epilepsy, idiopathic generalized 29.3 SCN2A SCN1A PNPO KCNQ2 CDKL5
31 childhood absence epilepsy 29.2 SCN2A SCN1A KCNQ2 CELF4 CDKL5
32 focal epilepsy 29.0 TBC1D24 SCN2A SCN1A MECP2 KCNQ2 CDKL5
33 west syndrome 28.8 TBC1D24 SCN2A SCN1A PNPO MECP2 KCNQ2
34 epilepsy 28.7 TBC1D24 SCN2A SCN1A PNPO MECP2 KCNQ2
35 pervasive developmental disorder 28.5 SCN2A SCN1A NLGN1 MECP2 CELF4 CDKL5
36 benign epilepsy with centrotemporal spikes 28.2 TBC1D24 SCN2A SCN1A MECP2 KCNQ2 CELF4
37 early infantile epileptic encephalopathy 27.9 TBC1D24 SCN2A SCN1A PNPO MECP2 KCNQ2
38 autism 27.9 SEZ6L2 SCN2A SCN1A NLGN1 MTR MECP2
39 multiple congenital anomalies-hypotonia-seizures syndrome 2 12.5
40 generalized epilepsy with febrile seizures plus, type 9 12.5
41 seizures, sensorineural deafness, ataxia, mental retardation, and electrolyte imbalance 12.5
42 multiple congenital anomalies-hypotonia-seizures syndrome 1 12.5
43 multiple congenital anomalies-hypotonia-seizures syndrome 3 12.5
44 microcephaly, seizures, and developmental delay 12.4
45 microcephaly, short stature, and polymicrogyria with or without seizures 12.4
46 febrile seizures, familial, 4 12.4
47 seizures, benign familial infantile, 2 12.4
48 seizures, benign familial neonatal, 1 12.4
49 seizures, scoliosis, and macrocephaly/microcephaly syndrome 12.4
50 microcephaly, progressive, with seizures and cerebral and cerebellar atrophy 12.4

Comorbidity relations with Seizure Disorder via Phenotypic Disease Network (PDN):


Acute Cystitis

Graphical network of the top 20 diseases related to Seizure Disorder:



Diseases related to Seizure Disorder

Symptoms & Phenotypes for Seizure Disorder

UMLS symptoms related to Seizure Disorder:


seizures, tremor, back pain, pain, headache, syncope, chronic pain, sciatica, vertigo/dizziness, sleeplessness, non-epileptic convulsion

MGI Mouse Phenotypes related to Seizure Disorder:

45
# Description MGI Source Accession Score Top Affiliating Genes
1 mortality/aging MP:0010768 9.73 CELF4 CILK1 DIAPH1 HMGCR KCNQ2 MECP2
2 nervous system MP:0003631 9.36 CDKL5 CELF4 CILK1 DIAPH1 KCNQ2 MECP2

Drugs & Therapeutics for Seizure Disorder

Drugs for Seizure Disorder (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 827)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Ethosuximide Approved Phase 4 77-67-8 3291
2
Nitrazepam Approved Phase 4 146-22-5 4506
3
Milnacipran Approved, Investigational Phase 4 92623-85-3 65833
4
Levomilnacipran Approved, Investigational Phase 4 96847-54-0
5
Lumefantrine Approved Phase 4 82186-77-4 6437380
6
Artemether Approved Phase 4 71963-77-4 119380 68911
7
Phenytoin Approved, Vet_approved Phase 4 57-41-0 1775
8
Verapamil Approved Phase 4 52-53-9 2520
9
Diazepam Approved, Illicit, Investigational, Vet_approved Phase 4 439-14-5 3016
10
Ivermectin Approved, Investigational, Vet_approved Phase 4 70288-86-7 6474909
11
Methylphenidate Approved, Investigational Phase 4 113-45-1 4158
12
Sevoflurane Approved, Vet_approved Phase 4 28523-86-6 5206
13
Morphine Approved, Investigational Phase 4 57-27-2 5288826
14
Diclofenac Approved, Vet_approved Phase 4 15307-86-5 3033
15
Methohexital Approved Phase 4 151-83-7 9034
16
Bupropion Approved Phase 4 34841-39-9, 34911-55-2 444
17
Metoclopramide Approved, Investigational Phase 4 364-62-5 4168
18
Olanzapine Approved, Investigational Phase 4 132539-06-1 4585
19
Risperidone Approved, Investigational Phase 4 106266-06-2 5073
20
Nicotine Approved Phase 4 54-11-5 942 89594
21
Celecoxib Approved, Investigational Phase 4 169590-42-5 2662
22
Mirtazapine Approved Phase 4 85650-52-8, 61337-67-5 4205
23
Risedronate Approved, Investigational Phase 4 105462-24-6 5245
24
Ziprasidone Approved Phase 4 146939-27-7 60854
25
Labetalol Approved Phase 4 36894-69-6 3869
26
Cosyntropin Approved Phase 4 16960-16-0 16129617
27
Sodium citrate Approved, Investigational Phase 4 68-04-2
28
Vidarabine Approved, Investigational Phase 4 24356-66-9 32326 21704
29
Cycloserine Approved Phase 4 68-41-7 401 6234
30
Levodopa Approved Phase 4 59-92-7 6047
31
Guanfacine Approved, Investigational Phase 4 29110-47-2 3519
32
Cysteamine Approved, Investigational Phase 4 60-23-1 6058
33
Guaifenesin Approved, Investigational, Vet_approved Phase 4 93-14-1 3516
34
Imipramine Approved Phase 4 50-49-7 3696
35
Norepinephrine Approved Phase 4 51-41-2 439260
36
Furosemide Approved, Vet_approved Phase 4 54-31-9 3440
37
Nortriptyline Approved Phase 4 72-69-5 4543
38
Clevidipine Approved, Investigational Phase 4 167221-71-8
39
Hydralazine Approved Phase 4 86-54-4 3637
40
Clonidine Approved Phase 4 4205-90-7 2803
41
Ticagrelor Approved Phase 4 274693-27-5 9871419
42
Acarbose Approved, Investigational Phase 4 56180-94-0 441184
43
Liraglutide Approved Phase 4 204656-20-2 44147092
44
Pasireotide Approved Phase 4 396091-73-9 9941444
45
Parecoxib Approved Phase 4 198470-84-7
46
Dobutamine Approved Phase 4 34368-04-2 36811
47
Codeine Approved, Illicit Phase 4 76-57-3 5284371
48
Entecavir Approved, Investigational Phase 4 142217-69-4 153941
49
Lamivudine Approved, Investigational Phase 4 134678-17-4 60825
50
Peginterferon alfa-2b Approved Phase 4 99210-65-8, 215647-85-1

Interventional clinical trials:

(show top 50) (show all 2887)
# Name Status NCT ID Phase Drugs
1 Prospective Open Label Evaluation of Clobazam Adjunctive Treatment of Adults With Refractory Focal Epilepsy: A Pilot Study Unknown status NCT02726919 Phase 4 Clobazam
2 A Randomised Controlled Trial of the Ketogenic Diet in the Treatment of Epilepsy in Children Under the Age of Two Years Unknown status NCT02205931 Phase 4 Antiepileptic drug therapy
3 Study to Improve the Treatment of Epilepsy (SITE). A Randomized Study Comparing Adjustment of Treatment to Reduce Side Effects of Antiepileptic Drugs With Continuing Treatment Unchanged Unknown status NCT00133081 Phase 4 All registered antiepileptic drugs
4 Immunotherapy in Intractable Cryptogenic Epilepsy Patients With Autoimmune Antibody Unknown status NCT02695797 Phase 4 Prednisolone
5 Efficacy of Levetiracetam in Control of Neonatal Seizures Unknown status NCT03107507 Phase 4 Levetiracetam;Phenobarbital
6 The Impact of Reducing Overtreatment on Quality of Life in Children With Refractory Epilepsy Unknown status NCT00647322 Phase 4
7 Comparing Ketogenic Diet With the Most Appropriate Antiepileptic Drug- a Randomized Study of Children With Mental Retardation and Drug Resistant Epilepsy Unknown status NCT00552526 Phase 4 Antiepileptic drug (AED)
8 A Randomized Controlled Trial of Generic Substitution of Antiepileptic Drugs Unknown status NCT02429596 Phase 4 Experimental
9 Double Blind, Randomised, Cross-over Study Melatonin Versus Placebo in the Lennox-Gastaut Syndrome: Neurophysiological and Neuropsychological Effects Unknown status NCT01370486 Phase 4 melatonin;placebo
10 Hormone Profiles in Adults Treated With Valproate vs. Lamotrigine Monotherapy for Newly Diagnosed Epilepsy: A Prospective Randomised Study Unknown status NCT00137709 Phase 4 Sodium valproate;Lamotrigine
11 Levetiracetam Treatment of Children With Subclinical Sleep-Activated Epileptiform Activity (SSEA) - a Placebo Controlled Double-blind Cross-over-study Unknown status NCT00393614 Phase 4 levetiracetam
12 Evaluation of Onfi Conversion Therapy Replacing Clonazepam in Patients With Medically Refractory Epilepsy: Efficacy, Tolerability, Dosing Equivalence, and Retention Rate Unknown status NCT01932502 Phase 4 clobazam (Onfi);Initial conversion and titration;Conversion schedule - Week 1;Conversion schedule - Week 2;Conversion schedule - Week 3
13 Hyperventilation and ECT Seizure Duration: Effects on Cerebral Oxygen Saturation, and Therapeutic Outcome With Comparisons Between Etomidate and Ketamine in Patients With Major Depressive Disorder Unknown status NCT02924090 Phase 4 Etomidate;Ketamine
14 Effects of Perampanel on Cognition and Electroencephalography in Patients With Epilepsy Unknown status NCT02900755 Phase 4 Perampanel
15 Melatonin Use in the Intensive Care Elderly Population Unknown status NCT03013790 Phase 4 Melatonin
16 Combining Propofol With Therapeutic Hypothermia for Improving Survival and Neurological Prognoses in Patients Resuscitated From Cardiac Arrest Unknown status NCT02367755 Phase 4 Propofol;Lorazepam
17 Turgut Ozal Medical Center Department of Anesthesiology and Reanimation Unknown status NCT02267980 Phase 4 Sevoflurane;Ketamine;Saline
18 Efficacy of Phenytoin in the Prophylaxis of Seizures of Patients With Pneumococcal Meningitis at Least 50 Yrs Old. A Multi-center Comparative Randomized Double-blind and Placebo-controlled Clinical Trial Unknown status NCT01478035 Phase 4 Phenytoin;placebo
19 Inonu University, Turgut Ozal Medical Center, Department of Anesthesiology and Reanimation Malatya Unknown status NCT02271555 Phase 4 Sevoflurane;Remifentanil;Saline
20 The Benefit of Prophylactic Anticonvulsant in Post Cardiac Arrest Syndrome With Induced Mild Hypothermia Unknown status NCT01083784 Phase 4 Use of prophylactic anticonvulsants (valproate, clonazepam);Control group
21 Conversion From Multiple-Daily Dose Enteric-Coated Depakote to Once-Daily Depakote ER in Elderly Outpatients With Epilepsy or Behavioral Disturbances: Unknown status NCT00312676 Phase 4
22 Relationship Between Topiramate Use and Ocular Angle Status: A Prospective Pilot Study Unknown status NCT00153699 Phase 4 Topiramate
23 Effects on the Diagnostic Accuracy of Magnetic Imaging Angiographies of the Supra-Aortic Vessels by Three Different Magnetic Resonance Contrast Agents in Patients With Headache and Dizziness or Epilepsy and Clinical Indication for an Angiography by Magnetic Imaging Unknown status NCT00132223 Phase 4 Contrast agent
24 Buccal Midazolam Versus Nasal or Oral Midazolam Sedation for Minor Invasive Procedures in Children: A Prospective Randomized Control Study Unknown status NCT02408302 Phase 4 Midazolam
25 Open Label Study of Milnacipran in the Preventive Treatment of Episodic Migraine With and Without Aura and Chronic Migraine. Unknown status NCT01319825 Phase 4 milnacipran
26 Comparison of Oral 30 % Dextrose and iv Midazolam Sedation During MRI in Neonates Unknown status NCT02645279 Phase 4 IV midazolam
27 A Randomized Controlled Trial Comparing the Adductor Canal Catheter (ACC) and Intra-articular Catheter (IAC) Following Primary Total Knee Arthroplasty Unknown status NCT02497911 Phase 4 Ropivicaine;Bupivicaine
28 The Effect of Central Insulin on Insulin Sensitivity and Energy Metabolism Unknown status NCT01479075 Phase 4 intransal insulin;Placebo
29 A Double-Blinded Randomized Controlled Trial Comparing the Adductor Canal Catheter (ACC) and Local Infiltration of Analgesia (LIA) Following Primary Total Knee Arthroplasty Unknown status NCT02603900 Phase 4 ropivacaine;bupivacaine
30 The Safety and Immunogenicity Study of Rotavirus Vaccine Simultaneously Vaccinated With MR or MMR Vaccine Unknown status NCT02153866 Phase 4
31 Effect of Bispectral Index (BIS) Monitoring on Faster Recovery Time and Analgesic Consumption in Abdominal Surgery Patients Unknown status NCT01470898 Phase 4
32 Treatment With Acetyl-Choline Esterase Inhibitors in Children With Autism Unknown status NCT01098383 Phase 4 Acetyl-Choline Esterase Inhibitors and Choline supplements;Indistinguishable placebo tablets, matching both donepezil and choline
33 Pharmacokinetic/Pharmacodynamic Model of Propofol in Children Unknown status NCT02544854 Phase 4 Propofol
34 A Randomized Control Trial of Vitamin D Prophylaxis in the Prevention of Hypertensive Disorders of Pregnancy Unknown status NCT02920593 Phase 4 Vitamin D3
35 Morphine Versus Methadone for Opiate Exposed Infants With Neonatal Abstinence Syndrome Unknown status NCT02851303 Phase 4 Morphine;Methadone
36 Evaluation Whether Higher Retention Rate is in Those of Combined Methadone With N-Acetyl-Cysteine Compared to Those With Methadone Alone During a Six-month Study Unknown status NCT01047956 Phase 4 Methadone; NAC;Methadone
37 DDAVP vs Exercise in Patients With Mild Hemophilia A - Which is Better and do They Work Synergistically in Improving Hemostasis? Unknown status NCT03136003 Phase 4 DDAVP
38 Treatment for Alcohol Dependence With Gabapentin: A Double Blind Placebo Controlled Randomized Clinical Trial Unknown status NCT02771925 Phase 4 Gabapentin 2g/day divided in two doses for 24 weeks;Placebo 2g/day divided in two doses for 24 weeks
39 Effect of Botox Treatment for Neurogenic Detrusor Overactivity on the Prevention of Autonomic Dysreflexia Following Spinal Cord Injury Unknown status NCT02298660 Phase 4 BOTOX
40 Antispastic Effect of Transcranial Magnetic Stimulation in Patients With Cerebral and Spinal Spasticity Unknown status NCT01786005 Phase 4
41 Efficacy and Safety of Artemether + Lumefantrine and Dihydroartemisinin + Piperaquine for the Treatment of Uncomplicated Malaria in Guinea-Bissau. Unknown status NCT01704508 Phase 4 Artemether-lumefantrine;Dihydroartemisinin-piperaquine
42 A Randomized, Open Label, Comparative, Multi-center Clinical Trial to Determine the Efficacy and Safety of Topiramate Comparing With Carbamazepine in Benign Rolandic Epilepsy. Completed NCT00216567 Phase 4 topamax
43 A 24-Week Prospective, Open-Label, Multicenter Study to Evaluate the Effect on Seizure Frequency, Safety and Tolerability of Oxcarbazepine Monotherapy in Adult Patients With Partial Seizures Completed NCT00275925 Phase 4 Oxcarbazepine
44 A Randomized, Double-blind, Parallel-group Multi-center Comparative Flexible-dose Trial Of Pregabalin Versus Gabapentin As Adjunctive Therapy In Subjects With Partial Seizures. Completed NCT00537940 Phase 4 Pregabalin;Gabapentin
45 A 24-week Prospective Open-label Multicenter Study to Evaluate the Effect on Seizure Frequency, Safety and Tolerability of Oxcarbazepine Monotherapy in Children With Partial Seizures Completed NCT00275912 Phase 4 Oxcarbazepine
46 OAETREAT Extra Ivermectin Treatment of Persons With Onchocerciasis-associated Epilepsy: a Completed NCT03852303 Phase 4 ivermectin
47 A Korean Open-label, Multi-center, Community-based Trial Assessing the Efficacy and Safety of Zonisamide as Adjunctive Therapy in Patients With Uncontrolled Partial Epilepsy Completed NCT01140867 Phase 4 zonisamide
48 IV Keppra in the Emergency Department for Prevention of Early Recurrent Seizures Completed NCT00510783 Phase 4 Keppra;Fosphenytoin;Dilantin
49 A Randomized, Open-label, Parallel Group, Multi-center, Comparative, Phase IV Trial of Levetiracetam (LEV) Versus Topiramate (TPM) as Adjunctive Therapy to Evaluate Efficacy and Safety in Subjects With Refractory Partial Onset Seizures Completed NCT01229735 Phase 4 Levetiracetam;Topiramate
50 Double-Blind, Placebo-Controlled Trial of Vitamin E as Add-on Therapy for Children With Epilepsy Completed NCT00004637 Phase 4 Vitamin E

Search NIH Clinical Center for Seizure Disorder

Inferred drug relations via UMLS 71 / NDF-RT 50 :


Anti-epileptic Agent [EPC]
Divalproex Sodium
Ethosuximide
Ethotoin
felbamate
fosphenytoin
Fosphenytoin sodium
gabapentin
gabapentin enacarbil
lacosamide
lamotrigine
Levetiracetam
Mephenytoin
methsuximide
oxcarbazepine
Phenytoin
Phenytoin sodium
PHENYTOIN SODIUM,EXTENDED
PHENYTOIN SODIUM,PROMPT
Primidone
Sodium Valproate
tiagabine
Tiagabine hydrochloride
topiramate
Trimethadione
Valproic Acid
Vigabatrin
zonisamide

Genetic Tests for Seizure Disorder

Genetic tests related to Seizure Disorder:

# Genetic test Affiliating Genes
1 Seizures 29
2 Seizure 29

Anatomical Context for Seizure Disorder

MalaCards organs/tissues related to Seizure Disorder:

40
Brain, Temporal Lobe, Cortex, Testes, Amygdala, Heart, Bone

Publications for Seizure Disorder

Articles related to Seizure Disorder:

(show top 50) (show all 31689)
# Title Authors PMID Year
1
ECS Dynamism and Its Influence on Neuronal Excitability and Seizures. 61 42
30879174 2019
2
Testicular mixed germ cell tumor presenting with seizure as the initial symptom: a case report and literature review. 42
30912892 2019
3
Closing the Disclosure Gap: Medical Errors in Pediatrics. 42
30867262 2019
4
Astrocytic modulation of potassium under seizures. 61
31823867 2020
5
Activation of small conductance calcium-activated potassium channels suppresses seizure susceptibility in the genetically epilepsy-prone rats. 61
31783064 2020
6
Consensus statement for the management of generalized tonic-clonic seizures in Spain. 61
31529468 2020
7
Reconfiguration of dynamic large-scale brain network functional connectivity in generalized tonic-clonic seizures. 61
31517428 2020
8
Safety and efficacy of adjunctive cenobamate (YKP3089) in patients with uncontrolled focal seizures: a multicentre, double-blind, randomised, placebo-controlled, dose-response trial. 61
31734103 2020
9
The effect of the guidelines for management of febrile seizures 2015 on clinical practices: Nationwide survey in Japan. 61
31604594 2020
10
Expediting the sampling, decalcification, and forensic DNA analysis of large elephant ivory seizures to aid investigations and prosecutions. 61
31670244 2020
11
Involvement of peroxisome proliferator-activated receptor γ in anticonvulsant activity of α-asaronol against pentylenetetrazole-induced seizures in zebrafish. 61
31493468 2020
12
Tripolar concentric EEG electrodes reduce noise. 61
31809982 2020
13
Low-dose intranasal insulin improves cognitive function and suppresses the development of epilepsy. 61
31557476 2020
14
International meeting on Wolf-Hirschhorn syndrome: Update on the nosology and new insights on the pathogenic mechanisms for seizures and growth delay. 61
31769173 2020
15
An unusual case of acoria in Sturge-Weber syndrome. 61
30295080 2020
16
Intraparenchymal hemorrhage and cerebral venous thrombosis in an adult with congenital porencephalic cyst presenting for generalized tonic-clonic seizures. 61
31762865 2020
17
[Focal epileptic seizures mimicking a stroke: neuroimaging and electroencephalographic correlations]. 61
31845754 2020
18
Brain-heart interaction revisited: Takotsubo syndrome secondary to seizures. 61
31495491 2020
19
Rational polytherapy in the treatment of cholinergic seizures. 61
31454548 2020
20
Seizures in infancy in the offspring of women with epilepsy. 61
31532859 2020
21
Nonconvulsive Seizures in Abusive Head Trauma. 61
31552777 2020
22
BET 2: Is keeping the eyes shut while fitting predictive of a psychogenic cause for seizures? 61
31848267 2020
23
Layer- and Cell-Specific Recruitment Dynamics during Epileptic Seizures In Vivo. 61
31657482 2020
24
Establishing functional brain networks using a nonlinear partial directed coherence method to predict epileptic seizures. 61
31614163 2020
25
Corrigendum to "Febrile seizures: Are they truly benign? Longitudinal analysis of risk factors and future risk of afebrile epileptic seizure based on the national sample cohort in South Korea, 2002-2013" [Seizure 64 (January) (2019) 77-83]. 61
31416672 2019
26
Novel study design to assess the efficacy and tolerability of antiseizure medications for focal-onset seizures in infants and young children: A consensus document from the regulatory task force and the pediatric commission of the International League against Epilepsy (ILAE), in collaboration with the Pediatric Epilepsy Research Consortium (PERC). 61
31819909 2019
27
Neuron specific enolase as a marker of seizure related neuronal injury. 61
31404559 2019
28
Single amyloid-beta injection exacerbates 4-aminopyridine-induced seizures and changes synaptic coupling in the hippocampus. 61
31381216 2019
29
Independent Risk Factors for Postoperative Seizures in Chronic Subdural Hematoma Identified by Multiple Logistic Regression Analysis. 61
31421304 2019
30
Ictal cerebral blood flow in psychogenic non-epileptic seizures: a preliminary SPECT study. 61
31040173 2019
31
Effectiveness and safety of perampanel as early add-on treatment in patients with epilepsy and focal seizures in the routine clinical practice: Spain prospective study (PERADON). 61
31812902 2019
32
Pharmacokinetic interaction of brivaracetam on other antiepileptic drugs in adults with focal seizures: Pooled analysis of data from randomized clinical trials. 61
31675621 2019
33
Cardiac stress after electroconvulsive therapy and spontaneous generalized convulsive seizures: A prospective echocardiographic and blood biomarker study. 61
31675603 2019
34
Psychogenic nonepileptic seizures: Comparing what South African healthcare providers communicate to patients at the point of diagnosis against international guidelines. 61
31698264 2019
35
A New Case with Corpus Callosum Abnormalities, Microcephaly and Seizures Associated with a 2.3-Mb 1q43-q44 Deletion. 61
31830750 2019
36
Tranexamic acid and convulsive seizures after off-pump coronary artery bypass surgery: the role of renal insufficiency. 61
31408168 2019
37
Distinct effects of resveratrol on seizures and hyperexcitability induced by NMDA and 4-aminopyridine. 61
29642764 2019
38
Lower Serum Iron and Hemoglobin Levels are Associated with Acute Seizures in Patients with Ruptured Cerebral Aneurysms. 61
31161421 2019
39
Comparison Between Efficacy of Melatonin and Diazepam for Prevention of Recurrent Simple Febrile Seizures: A Randomized Clinical Trial. 61
31521449 2019
40
Regional and temporal regulation and role of somatostatin receptor subtypes in the mouse brain following systemic kainate-induced acute seizures. 61
30685491 2019
41
Epileptic seizures and outcome in different subtypes of subarachnoid haemorrhage - Results of a single-center retrospective analysis. 61
31427240 2019
42
Psychoanalytical concepts of epilepsy. 61
31732330 2019
43
Seasonal distribution of febrile seizure and the relationship with respiratory and enteric viruses in Korean children based on nationwide registry data. 61
31675516 2019
44
Regression of Epileptogenesis by Inhibiting Tropomyosin Kinase B Signaling following a Seizure. 61
31525273 2019
45
Current Status of Continuous Electroencephalographic Monitoring in Critically Ill Children. 61
31493974 2019
46
Rhythmic ictal nonclonic hand (RINCH) motions in general EMU patients with focal epilepsy. 61
31848102 2019
47
[Mobile seizure monitoring in epilepsy patients]. 61
31673723 2019
48
Potential role of cannabidiol for seizure control in a patient with recurrent glioma. 61
31848037 2019
49
The Epidemiology of Epilepsy. 61
31852003 2019
50
Epileptic activity in neurological deterioration after ischemic stroke, a continuous EEG study. 61
31594733 2019

Variations for Seizure Disorder

ClinVar genetic disease variations for Seizure Disorder:

6 ‎‎ ‎‎ ‎‎
# Gene Name Type Significance ClinVarId dbSNP ID GRCh37 Pos GRCh38 Pos
1 MTR NM_000254.2(MTR):c.3518C>T (p.Pro1173Leu)SNV Pathogenic/Likely pathogenic 14278 rs121913578 1:237058770-237058770 1:236895470-236895470
2 DIAPH1 NM_005219.5(DIAPH1):c.2332C>T (p.Gln778Ter)SNV Pathogenic/Likely pathogenic 183344 rs730882242 5:140953085-140953085 5:141573518-141573518
3 SCN1A NM_006920.6(SCN1A):c.1625G>A (p.Arg542Gln)SNV Conflicting interpretations of pathogenicity 68588 rs121918817 2:166901590-166901590 2:166045080-166045080

Expression for Seizure Disorder

Search GEO for disease gene expression data for Seizure Disorder.

Pathways for Seizure Disorder

Pathways related to Seizure Disorder according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1 11.79 SCN2A SCN1A MECP2 KCNQ2
2
Show member pathways
11.43 SCN2A SCN1A KCNQ2
3 10.28 SCN2A SCN1A KCNQ2

GO Terms for Seizure Disorder

Cellular components related to Seizure Disorder according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 axon initial segment GO:0043194 9.26 SCN1A KCNQ2
2 voltage-gated sodium channel complex GO:0001518 9.16 SCN2A SCN1A
3 sodium channel complex GO:0034706 8.96 SCN2A SCN1A
4 node of Ranvier GO:0033268 8.8 SCN2A SCN1A KCNQ2

Biological processes related to Seizure Disorder according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 regulation of ion transmembrane transport GO:0034765 9.54 SCN2A SCN1A KCNQ2
2 neuron projection development GO:0031175 9.43 TBC1D24 NLGN1 MECP2
3 positive regulation of dendritic spine development GO:0060999 9.32 NLGN1 CDKL5
4 membrane depolarization during action potential GO:0086010 9.16 SCN2A SCN1A
5 neuromuscular process controlling posture GO:0050884 8.96 SCN1A MECP2
6 regulation of respiratory gaseous exchange by neurological system process GO:0002087 8.62 NLGN1 MECP2

Molecular functions related to Seizure Disorder according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 voltage-gated sodium channel activity GO:0005248 8.96 SCN2A SCN1A
2 voltage-gated ion channel activity GO:0005244 8.8 SCN2A SCN1A KCNQ2

Sources for Seizure Disorder

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
53 NINDS
54 Novoseek
56 OMIM
57 OMIM via Orphanet
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....